An oropharyngeal pH monitoring device to evaluate patients with chronic laryngitis

Neurogastroenterology and Motility

Volumn 25, Issue 5, 2013, Pages

  Yuksel, E S ^a   Slaughter, J C ^b   Mukhtar, N ^a   Ochieng, M ^a   Sun, G ^a   Goutte, M ^a   Muddana, S ^a   Gaelyn Garrett, C ^c   Vaezi, M F ^a  

^a Hepatology and Nutrition   (United States)

^b Department of Biostatistics ^*  (United States)

^c Vanderbilt Voice Center   (United States)

Author keywords

Diagnosis; Esophageal acid exposure; Heartburn; Restech

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HOARSENESS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LARYNGITIS; MALE; MEDICAL DEVICE; OROPHARYNGEAL PH MONITORING DEVICE; PH; PH MEASUREMENT; PREVALENCE; PRIORITY JOURNAL; STANDING;

ADULT; ESOPHAGEAL PH MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; LARYNGITIS; MALE; MIDDLE AGED; OROPHARYNX; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84876725242     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12109     Document Type: Article

References (23)

1. Locke GR 3rd, Talley NJ, Fett SL et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 1448-56.
2. Dent J, El-Serag HB, Wallander MA et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005; 54: 710-7.
3. Frye JW, Vaezi MF. Extraesophageal GERD. Gastroenterol Clin North Am 2008; 37: 845-58. ix.
4. Vaezi MF, Hicks DM, Abelson TI et al. Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association. Clin Gastroenterol Hepatol 2003; 1: 333-44.
5. Vakil N, van Zanten SV, Kahrilas P et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-20. quiz 1943.
6. Fletcher KC, Goutte M, Slaughter JC et al. Significance and degree of reflux in patients with primary extraesophageal symptoms. Laryngoscope 2011; 121: 2561-65.
7. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991; 101(4 Pt 2 Suppl. 53): 1-78.
8. Francis DO, Rymer J, Slaughter JC et al. High economic burden of caring for patients with suspected extraesophageal reflux. Am J Gastroenterol 2013. (in press).
9. Ahmed T, Vaezi MF. The role of pH monitoring in extraesophageal gastroesophageal reflux disease. Gastrointest Endosc Clin N Am 2005; 15: 319-31.
10. Vaezi MF. CON: treatment with PPIs should not be preceded by pH monitoring in patients suspected of laryngeal reflux. Am J Gastroenterol 2006; 101: 8-10.
11. Wiener GJ, Tsukashima R, Kelly C et al. Oropharyngeal pH monitoring for the detection of liquid and aerosolized supraesophageal gastric reflux. J Voice 2009; 23: 498-504.
12. Sun G, Muddana S, Slaughter JC et al. A new pH catheter for laryngopharyngeal reflux: normal values. Laryngoscope 2009; 119: 1639-43.
13. Ayazi S, Lipham JC, Hagen JA et al. A new technique for measurement of pharyngeal pH: normal values and discriminating pH threshold. J Gastrointest Surg 2009; 13: 1422-9.
14. Chheda NN, Seybt M, Schade RR, Postma GN. Normal values for pharyngeal monitoring. Ann Otol Rhinol Laryngol 2009; 118: 166-71.
15. Kawamura O, Aslam M, Rittmann T et al. Physical and pH properties of gastroesophagopharyngeal refluxate: a 24-hour simultaneous ambulatory impedance and pH monitoring study. Am J Gastroenterol 2004; 99: 1000-10.
16. Williams RB, Ali GN, Wallace KL, Wilson JS, De Carle DJ, Cook IJ. Esophagopharyngeal acid regurgitation; dual pH monitoring criteria for its detection and insights into mechanisms. Gastroenterology 1999; 117: 1051-61.
17. Vaezi MF, Schroeder PL, Richter JE. Reproducibility of proximal probe pH parameters in 24-hour ambulatory esophageal pH monitoring. Am J Gastroenterol 1997; 92: 825-9.
18. Shaker R, Bardan E, Gu C et al. Intrapharyngeal distribution of gastric acid refluxate. Laryngoscope 2003; 113: 1182-91.
19. Wiener GJ, Koufman JA, Wu WC et al. Chronic hoarseness secondary to gastroesophageal reflux disease: documentation with 24-h ambulatory pH monitoring. Am J Gastroenterol 1989; 84: 1503-8.
20. Adhami T, Goldblum JR, Richter JE et al. The role of gastric and duodenal agents in laryngeal injury: an experimental canine model. Am J Gastroenterol 2004; 99: 2098-106.
21. Francis DO, Goutte M, Slaughter JC et al. Traditional reflux parameters and not impedance monitoring predict outcome after fundoplication in extraesophageal reflux. Laryngoscope 2011; 121: 1902-9.
22. DeVault KR. Catheter-based pH monitoring: use in evaluation of gastroesophageal reflux disease symptoms (on and off therapy). Gastrointest Endosc Clin N Am 2005; 15: 289-306.
23. Jamieson JR, Stein HJ, DeMeester TR et al. Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol 1992; 87: 1102-11.